Neuroanatomical focus for morphine and enkephalin-induced hypermotility.
D000818:Animals; D001058:Apomorphine / Q000008:administration & dosage / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D004347:Drug Interactions; D004745:Enkephalins / Q000008:administration & dosage / Q000494:pharmacology*; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced*; D007267:Injections; D007274:Injections, Intraperitoneal; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology; D009830:Olfactory Bulb / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors
D004745:Enkephalins; D009842:Oligopeptides; D009270:Naloxone; D009020:Morphine; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine